Per the 2019 FDA guidance on adaptive designs for clinical trials of drugs and biologics, an adaptive design is defined as “a clinical trial design that allows for prospectively planned modifications to one or more aspects of the design based on accumulating data from subjects in the trial”.

Adaptive designs require to put in place statistical and operational safeguards in order to maintain the validity and the integrity of the trial.

Jaeger Consulting © 2023